Coreg
Product Images NDC 54868-4424

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Coreg (NDC 54868-4424). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Coreg 12.5mg Tablet Label (12.5mg Package Label)

Packaging label for Coreg (Carvedilol) tablets by Physicians Total Care, Inc. Each tablet contains 12.5 mg of Carvedilol. The bottle contains 30 tablets. The label includes dosage information and caution that federal law prohibits dispensing without a prescription. Additional instructions and storage details are also present on the label.*

FDA Label Image

Coreg 25mg Tablet Label (25mg Package Label)

Coreg 25 mg tablets packaging label from Physicians Total Care, Inc. The label states the active ingredient carvedilol, package contains 30 tablets, and mentions federal law restricting dispensing without prescription. Additional storage instructions, lot number, expiration date, and barcode are visible.*

FDA Label Image

Coreg 3.125mg Tablets Label (3.125mg Package Label)

Coreg 3.125 mg tablets packaging label from Physicians Total Care, Inc. The label indicates each tablet contains 3.125 mg of carvedilol and lists the package count as 30 tablets. The label also includes cautionary text about dispensing, the NDC number 54868-4421-0, dosage instructions, storage conditions, lot number, and expiration date.*

FDA Label Image

Coreg 6.25mg Tablet Label (6.25mg Package Label)

Coreg 6.25 mg carvedilol tablets package label from Physicians Total Care, Inc. Contains 30 tablets per bottle. Label includes NDC 54868-4424-0 and caution indicating federal law prohibits dispensing without prescription. Additional dosing and storage instructions are printed on the label.*

FDA Label Image

Carvedilol Chemical Structure (Ff6cceab 1693 4f93 B23d 0e91dede15ee 05)

Chemical structure of the active ingredient in Coreg, showing a complex molecule with multiple rings including an indole group, ether linkages, and amine functionalities.*

FDA Label Image

Figure 1. Survival Analysis For Copernicus (intent-to-treat) (Ff6cceab 1693 4f93 B23d 0e91dede15ee 06)

A line graph comparing % mortality over months between placebo and carvedilol groups, showing lower mortality with carvedilol. The graph spans 0 to 21 months on the x-axis and 0 to 30% mortality on the y-axis, with a p-value of 0.0014 noted.*

FDA Label Image

Figure 2. Effects On Mortality For Subgroups In Copernicus (Ff6cceab 1693 4f93 B23d 0e91dede15ee 07)

A forest plot illustrating hazard ratios for different subgroups of patients. The subgroups include gender (men, women), age (<65, ≥65), race (non-black, black), diabetes status, ischemic status, heart rate (>70, <70), systolic blood pressure (≥120 mm Hg, <120 mm Hg), spironolactone use, and overall patients. Each subgroup has a corresponding point estimate with confidence intervals on a horizontal axis ranging approximately from 0.0 to 2.0.*

FDA Label Image

Figure 3. Survival Analysis For Capricorn (intent-to-treat) (Ff6cceab 1693 4f93 B23d 0e91dede15ee 08)

A line graph depicting % mortality over 30 months comparing Carvedilol and Placebo treatment groups. The horizontal axis shows time in months, and the vertical axis shows mortality percentage. Carvedilol shows consistently lower mortality rates than Placebo, with a noted P value of 0.03 indicating statistical significance.*

FDA Label Image

Figure 4. Effects On Mortality For Subgroups In Capricorn (Ff6cceab 1693 4f93 B23d 0e91dede15ee 09)

A forest plot displaying hazard ratios for various patient subgroups, comparing outcomes based on conditions such as age, gender, prior medication use, disease history, and clinical measurements like heart rate and blood pressure. The plot visually represents risk estimates with confidence intervals for each subgroup.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.